Skip to main content
. 2022 Jun 28;11(7):1278. doi: 10.3390/antiox11071278

Table 2.

Overview of novel potential therapeutic drugs that directly target the molecular pathways responsible for ROS generation.

Molecule Target Model Effect References
Vitamin E ROS NASH protection of structural components of cell membrane from peroxidation [127]
Silibin ROS ALD increased of GSH concentration [128]
Chlormethiazole CYP2E1 ALD reduction of proteasome proteolytic enzyme activity induced by ethanol [129]
Nrf2 activators Nrf2 NAFLD/NASH prevention of inflammation, trygliceride accumulation [130,131]
Ethyl pyruvate Nrf2 ALD increase of anti-inflammatory factors [132]
MCC950 NLPR3 NASH decrease of AST and ALT and liver inflammation [133,134]